Retinoid products are among the better-studied topical treatments, and they are also among the slowest to show results. The delay follows directly from the mechanism through which they act.
They work at the level of gene expression
Retinoids bind to receptors inside skin cells that regulate which genes are transcribed, altering the behaviour of the cell rather than acting on the surface.
Changed transcription leads to changed protein production, which then changes tissue structure, and each step in that chain takes time.
This is a different kind of action from a moisturiser or an occlusive product, which alter the surface immediately and reversibly.
Conversion steps determine potency
The active form binding the receptor is retinoic acid, and most over-the-counter products contain precursors that skin enzymes must convert.
Each conversion step loses material, so a precursor several steps removed is markedly weaker at the same concentration than the acid itself.
Weaker forms are correspondingly better tolerated, which is the trade being made when a gentler product is chosen over a prescription strength.
Turnover and collagen set the timescale
Skin cells migrate from the base of the epidermis to the surface over a period of weeks, so effects on texture appear only as newly influenced cells arrive.
Effects in the deeper dermis depend on collagen synthesis, which is slower still and accumulates over months of continued use.
This is why studies of retinoid effects on fine lines run for many months, and why judging a product after a few weeks measures irritation rather than benefit.
Early irritation is expected and temporary
The first weeks commonly bring dryness, flaking and redness as turnover accelerates before the barrier adjusts.
Reducing frequency, applying to dry skin and pairing with a simple moisturiser are the standard ways of working through that period.
Abandoning treatment during this phase is common and guarantees that no benefit is observed, since the benefit belongs to a later stage entirely.
Sun sensitivity and pregnancy require care
Accelerated turnover leaves the skin more vulnerable to ultraviolet exposure, which is why daytime sun protection is part of the routine rather than an addition.
Retinoids also degrade in light, which is the practical reason they are applied in the evening and packaged opaquely.
Oral retinoids carry serious risks in pregnancy and topical use is generally avoided then as a precaution, making this a treatment to discuss with a clinician when pregnancy is possible.